Urea cycle disorders are a group of inborn errors of metabolism caused by dysfunction of any of the six enzymes or two transport proteins involved in urea biosynthesis. In this paper, we report a patient who presented with neurological dysfunction and coma in the immediate postpartum period. She was misdiagnosed for many years as a case of multiple sclerosis. The importance of reporting this case is to illustrate that the wrong diagnosis of patients as being affected with multiple sclerosis for many years due to magnetic resonance imaging abnormalities rather than the classic relapsingremitting nature of the disease may lead to catastrophic consequences. The patient was treated with intravenous steroids several times, which is contraindicated in patients with urea cycle disorders as it may precipitate acute hyperammonemic attacks. In addition, the management of urea cycle disorder could have started earlier and avoided multiple admissions to the intensive care unit. We believe that the presence of symmetric hyperintense insular cortical changes are seen in multiple hyperammonemic processes, and in the context of the clinical presentation and high ammonia levels can be suggestive of a urea cycle disorder. For any patient presenting with atypical clinical features, images should be reviewed and discussed in detail with an experienced neuroradiologist. In addition, the ammonia levels should be checked if a urea cycle disorder is suspected.
Introduction
The urea cycle is the final pathway for amino acid catabolism with the end product being urea that is subsequently excreted through the renal route. Ammonia is a usual component of the body fluid that exists as ammonium ion. When the level of ammonia increases as a consequence of excess protein catabolism, it enters the urea cycle in the liver to be converted into urea before excretion (Figure 1 ). Urea cycle disorders are a group of inherited disorders caused by a defect in urea synthesis with subsequent hyperammonemia. Increased serum ammonia level, both acute and chronic, alters the brain neurotransmitter system. 1 In acute hyperammonemia, extracellular accumulation of glutamate in the brain activates the N-methyl-D-aspartate receptors, which can lead to seizures. On the other hand, chronic hyperammonemia leads to downregulation of glutamate receptors and increased GABAergic tone causing deterioration of consciousness level and cognitive functions. The genetic defect involves either one of the enzymes in the urea cycle or a transport protein related to the metabolic process. 2 In this paper, we report a patient who presented with neurological dysfunction and coma in the immediate postpartum period. She was misdiagnosed for many years as a case of multiple sclerosis.
Informed consent was obtained from the patient to publish the case report.
Case report
A 26-year-old woman presented one week postpartum with a 2-day history of dizziness, diminished level of consciousness, vomiting and seizures. She had been diagnosed with multiple sclerosis and depression 4 years earlier. At that time, she presented with a similar presentation and was given steroid therapy both intravenous and oral. There were no symptoms or signs suggestive of relapsing-remitting multiple sclerosis including sensorimotor, cerebellar, visual or spinal cord dysfunction. Magnetic resonance imaging (MRI) of the brain revealed high signal intensities in both the centrum semiovale and the intermediate white matter abutting the ventricular system ( Figure 2 ). The diagnosis of multiple sclerosis was mainly established based on MRI findings and was considered to be a radiologically isolated syndrome of multiple sclerosis. She had two previous, uneventful pregnancies but, unfortunately, both male children died in the immediate neonatal period. Unfortunately, detailed clinical and laboratory information of the two neonates was not available because she delivered in another hospital. There was no family history of a similar condition, and her past medical history was otherwise unremarkable. Clinical examination revealed a disoriented and agitated woman with normal vital signs and absence of meningismus. Her cranial nerve examination was normal, and motor functions demonstrated a normal power, brisk reflexes and downgoing toes. Five days after admission, her level of consciousness deteriorated, with a Glasgow coma scale score of 6/15. She was admitted to the intensive care unit, intubated and mechanically ventilated for airway protection. As part of the work-up for metabolic coma, her serum ammonia level was found to be very high, up to 274 mmol/L (normal range 10.71-32.13 mmol/L), and the diagnosis of urea cycle disorder was suspected (Figure 3 ). Other investigations for metabolic coma were unremarkable including renal profile and electrolytes. Serum quantitative plasma amino acid analysis revealed highly increased glutamine at 1400 mmol/L (normal range 390-650 mmol/L), increased lysine at 300 mmol/L (normal range 150-220 mmol/L) and normal ornithine and citrulline levels. Quantitative urine orotic acid was increased at 18 mmol/mmol creatinine. She was treated with haemodialysis, sodium benzoate, arginine, and she was started on a protein-restricted diet through a nasogastric feeding tube. Another MRI of the brain performed during this second admission revealed high signal intensities in the periventricular white matter and basal ganglia with an unusual imaging finding of relative T2 hyperintensity in the insular cortices bilaterally ( Figure 4 ). Cerebrospinal fluid (CSF) analysis was carried out and showed normal values including the absence of oligoclonal bands. Amino acid analysis in the CSF was not performed because the focus at that time was on the diagnosis of multiple sclerosis. The patient recovered completely, and she has remained asymptomatic since discharge from the hospital 5 years ago. The diagnosis of multiple sclerosis was excluded based on the previously mentioned clinical and paraclinical parameters, and a diagnosis of urea cycle disorder was genetically confirmed. Genetic analysis revealed a heterozygous pathogenic variant in the ornithine transcarbamylase (OTC) gene c.626 C > T (p.Ala209Val). 
Discussion
Adults with mild urea cycle disorder caused by partial enzymatic deficiency may have disease manifestations only during stressful medical conditions. Partial enzyme deficiency allows a patient to have a normal life for decades. Precipitating events include postpartum stress (as in our patient), surgery, parenteral nutrition with high nitrogen consumption and gastrointestinal bleeding. In those patients, a high ammonia level may present with variable clinical patterns with the main manifestations affecting the central nervous system. The suspicion for this metabolic disorder arises when patients present with an elevated blood ammonia level and neurological manifestation without underlying hepatocellular dysfunction. 3 Postpartum decompensation is well recognised in urea cycle disorders, and in our case this presentation related to stress accompanied by hyperammonemia is what led us to the diagnosis of urea cycle disorder. Clinical features range from agitation to coma in acute attacks and different degrees of cognitive impairment chronically. Other manifestations include sleep disorders, loss of appetite, ataxia and seizures. A blood ammonia level is the first laboratory test performed in patients with suspected urea cycle disorder. Although hyperammonemia is a non-specific marker of inadequate nitrogen detoxification, it is considered the hallmark for urea cycle disorders, and the absence of hyperammonemia in symptomatic patients renders a urea cycle disorder highly unlikely. It is important to emphasise that in between flare ups and when the patient is asymptomatic, ammonia levels normalise. This makes keeping a high index of suspicion and further biochemical and genetic work-up mandatory to score the diagnosis in these situations when ammonia levels are normal. In addition, other recommended blood work-ups include lactate, glucose, electrolytes and arterial blood gasses. 4 Patients with a true urea cycle disorder will typically have low blood urea nitrogen levels because of ureagenesis inhibition or low protein intake. This parameter might be considered as an important clinical clue for the diagnosis. In addition, they will typically have normal glucose and electrolyte levels with a high ammonia level and respiratory alkalosis (ammonia level of 150 mmol/L or higher in neonates and 100 mmol/L or more in older children and adults). However, it is not uncommon to have electrolyte disturbances or an even more complex acid-base status abnormality especially if patients develop severe seizures. Quantitative plasma amino acid analysis and urine orotate measurement can help to distinguish between the different types of urea cycle disorders. Molecular genetic analysis or enzyme assays are generally used to confirm the diagnosis. 5 MRI imaging in patients with late-onset urea cycle disorders typically shows white matter lesions that are hyperintense in both proton density and fluid-attenuated inversion recovery (FLAIR) images. Other MRI findings may include increased signal intensity in the cingulate gyri, frontal and temporal lobes and the insular regions. It is important to note that not all patients with urea cycle disorder will show these changes and the MRI could be absolutely normal, and sometimes the changes only appear following an acute hyperammonemic attack. 6 Although these changes are not specific for urea cycle disorders, we believe that the presence of symmetric hyperintense insular cortical changes are seen in multiple hyperammonemic processes, and in the context of the clinical presentation and high ammonia levels can be suggestive of a urea cycle disorder. Our patient presented initially with MRI findings similar to those seen in multiple sclerosis. The presence of the insular sign, the absence of dissemination in time and space, and the lack of spinal cord involvement led us to consider other pathology than multiple sclerosis.
OTC deficiency is the only X-linked inherited urea cycle disorder. Women with a pathogenic variant of OTC deficiency have a 50% chance of transmitting the pathogenic variant to each child. Males who inherit the pathogenic variant will be affected. Both of the neonates of this patient were male and both died in the immediate postpartum period. 7 We speculate that the death of her two neonates was in fact related to her current disease. Genetic analysis revealed The principles of the management of urea cycle disorders are to remove excess ammonia and prevent its production from protein metabolism. This can be achieved by haemodialysis and nitrogen-scavenging agents such as sodium phenylacetate and sodium benzoate. Dietary restriction of protein is an important aspect of management. Patients with severe forms of urea cycle disorders may require liver transplantation. 8 A thorough literature review did not reveal any cases of urea cycle disorders misdiagnosed for many years as multiple sclerosis. To avoid a delay in diagnosis, treating neurologists should look for atypical features of multiple sclerosis. In our case, these features include the clinical presentation in the form of coma, seizures and encephalopathy. Other features include lack of spinal cord involvement, clinical presentation related to stress only, strong personal history of death of two offspring in the immediate neonatal period, the absence of oligoclonal bands and the atypical MRI findings. The wrong diagnosis in this patient had serious consequences for the patient, including a delay in the diagnosis after each episode of coma. In addition, she had an unnecessary administration of steroids that are well known to precipitate the attacks and was subjected to the consequences of being labelled as a multiple sclerosis patient. The treating team did not apply McDonald criteria in this case, which could have prevented the misdiagnosis from the beginning. The elements that were not followed in McDonald criteria include clinical definition of attacks, dissemination in space and time and not performing CSF analysis at the time of diagnosis. Going back to the basics of history, physical examination, red flag recognition, and applying diagnostic criteria are of paramount importance for confirming or excluding the diagnosis. In addition, no counselling was offered to the patient and her husband for many years regarding the fate of her future pregnancies and the possibility of death if the conception is a male fetus. The specific genotype confirmed in this patient, c.626 C > T (p.Ala209Val), is typically lethal in the perinatal period. There is no intervention that would have led to an ordinary life and lifespan for the patient's deceased male children.
Conclusion
The importance of reporting this case is to illustrate that the wrong diagnosis of patients as being affected with multiple sclerosis for many years due to MRI abnormalities rather than the classic relapsingremitting nature of the disease may lead to catastrophic consequences. The patient was treated with intravenous steroids several times, which is contraindicated in patients with urea cycle disorders as it may precipitate acute hyperammonemic attacks. In addition, the management of urea cycle disorder could have started earlier and avoided multiple admissions to the intensive care unit. We believe that the presence of symmetric hyperintense insular cortical changes are seen in multiple hyperammonemic processes, and in the context of the clinical presentation and high ammonia levels can be suggestive of a urea cycle disorder. For any patient presenting with atypical clinical features, images should be reviewed and discussed in detail with an experienced neuroradiologist. In addition, the ammonia levels should be checked if a urea cycle disorder is suspected.
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